Citations

Clear

1031 citation(s) found for "Clark, AS".

Association of Early Inhaled Nitric Oxide With the Survival of Preterm Neonates With Pulmonary Hypoplasia
Ellsworth, Kevin, Ellsworth, Marc A., Weaver, Amy L. , Mara, Kristin C. , Clark, Reese H. , Carey, William A., Ellsworth, Kevin R, Mara, Kristin C

Mayo Clinic

JAMA Pediatrics | May 7, 2018 | Volume: 172 | Issue: 7 | Pages: e180761

10.1001/jamapediatrics.2018.0761 | PMID 29800952 Get It

1080 The Collaborative Care Visit Model: A New Way to Provide Ongoing Care Targeted to Long-Term Stable Positive Airway Pressure Users
Moore, Wendy , Burr, L E, McNamara, Sara, Clark, Peter, Peine, N A, Finstuen, Thomas, Herold, Daniel L., Brown, Vicki, Warner, Christopher H. , Trapp, Gerald, Olson, Eric J. , Auger, R. Robert , Louis, Erik K. St. , Junna, Mithri R. , St Louis, E K , Herold, Daniel L. , Lipford, Melissa C.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A401-A401

10.1093/sleep/zsy061.1079 Get It

Wellness Coaching to Improve Lifestyle Behaviors Among Adults With Prediabetes: Patients’ Experience and Perceptions to Participation
DeJesus, Ramona S. , Clark, Matthew M. , Hathaway, Julie, Wilson, Patrick M. , Link, Sara, Hathaway, Julie C, Link, Sara M, Rutten, Lila J. Finney , Sauver, Jennifer L. St.

Mayo Clinic

Journal of Patient Experience | April 20, 2018 | Volume: 5 | Issue: 4 | Pages: 314-319

10.1177/2374373518769118 | PMID 30574554 Get It

Background: Health and Wellness Coaching has been shown to enhance treatment outcomes in the primary care setting. However, little is known about the experience and perceptions of patients who worked with a wellness coach as an integrated member of their primary health-care team. Objective: This project assessed patients’ experience and obtained their perceptions on barriers and facilitators to participation in a primary care–based wellness coaching program. Method: A survey was mailed to 99 primary care patients with prediabetes who participated in a 12-week wellness coaching program. Results: Sixty-two (63%) completed the survey; responders felt that participation in the wellness coaching program helped move them toward healthier lifestyle behavior and created a personal vision of wellness. Major themes associated with participation were supportive coaching relationship, increased self-accountability, increased goal-setting, and healthy behavior strategies. No significant barrier to participation was reported. Conclusion: Participants reported highly positive experience with the program; how to best integrate health and wellness coaching into the primary care setting needs to be explored.
Fact Finders for Patient Safety: Are Gadolinium-Based Contrast Media Safe Alternatives to Iodinated Contrast Agents for the Safe Performance of Spinal Injection Procedures?
Popescu, Adrian, Patel, Jaymin , McCormick, Zachary L. , Maus, Timothy P. , Rodes, Meghan, Walega, David R., Smith, Clark C, McCormick, Zachary L , Smith, Clark

Mayo Clinic

Pain Medicine | April 11, 2018 | Volume: 19 | Issue: 10 | Pages: 2089-2090

10.1093/pm/pny090 | PMID 29767782 Get It

Improved Self-Acceptance, Quality of Life, and Stress Level from Participation in a Worksite Yoga Foundations Program: A Pilot Study
Casey, Lori J., Rooy, Kimberly M. Van, Sutherland, Stephanie J., Jenkins, Sarah M. , Rosedahl, Jordan K., Wood, Nadia , Ebbert, Jon O. , Egginton, Jason S. , Sim, Leslie , Clark, Matthew M. , Van Rooy, Kimberly M, Wood, Nadia G, Rooy, Kimberly M. Van, López-Jiménez, Francisco , Wood, Nadia

Mayo Clinic

International Journal of Yoga Therapy | March 29, 2018 | Volume: 28 | Issue: 1 | Pages: 15-21

10.17761/2018-00013r2 | PMID 29596005 Get It

Abstract Yoga is increasing in popularity in the United States and across the globe. However, most yoga programs are provided outside the worksite; although many companies offer worksite wellness programs, at present there is limited documentation regarding the potential benefits of participating in a worksite yoga program. Therefore, the purpose of this project was to examine the potential effect of a worksite yoga program on self-acceptance, quality of life, and perceived stress. A prospective cohort pilot study that examined a structured worksite yoga program was designed and tailored to individuals new to yoga. The 8-week Yoga Foundations program was conducted at an academic medical center's worksite wellness center with 86 subjects. Outcome measures were the 36-item Self-Acceptance Scale; a six-item quality-of-life measure that assesses overall, social, mental, physical, emotional, and spiritual well-being; and the ten-item Perceived Stress Scale. Participants demonstrated significant improvement in their overall self-acceptance (p < 0.001), quality of life (p < 0.001), and perceived stress (p < 0.001) levels. They also highly rated the yoga instructors and the weekly format of the program. Participation in a Yoga Foundations program was associated with improvements in self-acceptance, quality of life and stress levels in worksite wellness center members. Future studies should use randomized designs and examine other wellness domains to learn more about the potential benefits of worksite yoga programs.
Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [ 18 F]AV-1451 PET in Atypical Alzheimer’s Disease
Tetzloff, Katerina A. , Graff‐Radford, Jonathan , Martin, Peter R. , Tosakulwong, Nirubol , Senjem, Matthew L. , Spychalla, Anthony J., Drubach, Daniel A., Jack, Clifford R. , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Jack, Clifford R , Senjem, Matthew L , Machulda, Mary M. , Duffy, Joseph R. , Clark, Heather M. , Schwarz, Christopher G.

Mayo Clinic

Journal of Alzheimer’s Disease | March 28, 2018 | Volume: 62 | Issue: 4 | Pages: 1713-1724

10.3233/jad-170740 | PMID 29614676 Get It

Background: Despite common pathology, Alzheimer’s disease (AD) can have multiple clinical presentations which pathological studies suggest result from differences in the regional distribution of tau pathology. Positron emission tomography (PET) ligands are now available that can detect tau proteins in vivo and hence can be used to investigate the biological mechanisms underlying atypical AD. Objective: To assess regional patterns of tau uptake on PET imaging in two atypical AD variants, posterior cortical atrophy (PCA) and logopenic progressive aphasia (lvPPA). Methods: Eighteen PCA and 19 lvPPA subjects that showed amyloid-β deposition on PET underwent tau-PET imaging with [ 18 F]AV-1451. Group comparisons of tau uptake in PCA and lvPPA were performed using voxel-level and regional-level analyses. We also assessed the degree of lobar tau asymmetry and correlated regional tau uptake to age and performance on clinical evaluations. Results: Both syndromes showed diffuse tau uptake throughout all cortical regions, although PCA showed greater uptake in occipital regions compared to lvPPA, and lvPPA showed greater uptake in left frontal and temporal regions compared to PCA. While lvPPA showed predominant left-asymmetric tau deposition, PCA was more bilateral. Younger subjects showed greater tau uptake bilaterally in frontal and parietal lobes than older subjects, and sentence repetition, Boston naming test, simultanagnosia, and visuoperceptual function showed specific regional tau correlates. Conclusion: Tau deposition is closely related to clinical presentation in atypical AD with age playing a role in determining the degree of cortical tau deposition.
Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival
Rayfield, Corbin, Grady, Fillan S. , León, Gustavo De , Rockne, Russell C. , Jackson, Pamela , Vora, Mayur, Johnston, Sandra K. , Clark-Swanson, Kamala , Whitmire, Scott A., Gamez, Mauricio E. , Porter, Alyx B. , Hu, Leland , Gonzalez‐Cuyar, Luis F. , Vora, Sujay A., Swanson, Kristin R. , Rayfield, Corbin A, Grady, Fillan, De Leon, Gustavo, Rockne, Russell, Carrasco, Eduardo, Hawkins-Daarud, Andrea, Clark-Swanson, Kamala R., Whitmire, Scott, Porter, Alyx, Gonzalez-Cuyar, Luis, Vora, Sujay, Swanson, Kristin R , Carrasco, Eduardo , Hawkins‐Daarud, Andrea , Bendok, Bernard R.

Mayo Clinic

JCO Clinical Cancer Informatics | March 1, 2018 | Volume: No volume available | Issue: 2 | Pages: 1-14

10.1200/cci.17.00080 | PMID 30652553 Get It

PurposeDespite the intra- and intertumoral heterogeneity seen in glioblastoma multiforme (GBM), there is little definitive data on the underlying cause of the differences in patient survivals. Serial imaging assessment of tumor growth allows quantification of tumor growth kinetics (TGK) measured in terms of changes in the velocity of radial expansion seen on imaging. Because a systematic study of this entire TGK phenotype—growth before treatment and during each treatment to recurrence —has never been coordinately studied in GBMs, we sought to identify whether patients cluster into discrete groups on the basis of their TGK.Patients and MethodsFrom our multi-institutional database, we identified 48 patients who underwent maximally safe resection followed by radiotherapy with imaging follow-up through the time of recurrence. The patients were then clustered into two groups through a k-means algorithm taking as input only the TGK before and during treatment.ResultsThere was a significant survival difference between the clusters ( P = .003). Paradoxically, patients among the long-lived cluster had significantly larger tumors at diagnosis ( P = .027) and faster growth before treatment ( P = .003) but demonstrated a better response to adjuvant chemotherapy ( P = .048). A predictive model was built to identify which cluster patients would likely fall into on the basis of information that would be available to clinicians immediately after radiotherapy (accuracy, 90.3%).ConclusionDichotomizing the heterogeneity of GBMs into two populations—one faster growing yet more responsive with increased survival and one slower growing yet less responsive with shorter survival—suggests that many patients who receive standard-of-care treatments may get better benefit from select alternative treatments.
[18F]AV‐1451 tau‐PET and primary progressive aphasia
Josephs, Keith A. , Martin, Peter R. , Botha, Hugo , Schwarz, Christopher G. , Graff‐Radford, Jonathan , Weigand, Stephen D. , Senjem, Matthew L. , Utianski, Rene L. , Drubach, Daniel A., Petersen, Ronald C. , Jack, Clifford R. , Lowe, Val J. , Whitwell, Jennifer L. , Utianski, Rene L , Jack, Clifford R , Schwarz, Christopher G , Senjem, Matthew L , Botha, Hugo , Duffy, Joseph R. , Clark, Heather M. , Machulda, Mary M. , Boeve, Bradley F. , Jones, David T. , Knopman, David S. , Whitwell, Jennifer L.

Mayo Clinic

Annals of Neurology | February 16, 2018 | Volume: 83 | Issue: 3 | Pages: 599-611

10.1002/ana.25183 | PMID 29451323 Get It

ObjectivesTo assess [18F]AV‐1451 tau‐PET (positron emission tomography) uptake patterns across the primary progressive aphasia (PPA) variants (logopenic, semantic, and agrammatic), examine regional uptake patterns of [18F]AV‐1451 independent of clinical diagnosis, and compare the diagnostic utility of [18F]AV‐1451, [18F]‐fluorodeoxygluclose (FDG)‐PET and MRI (magnetic resonance imaging) to differentiate the PPA variants.MethodsWe performed statistical parametric mapping of [18F]AV‐1451 across 40 PPA patients (logopenic‐PPA = 14, semantic‐PPA = 13, and agrammatic‐PPA = 13) compared to 80 cognitively normal, Pittsburgh compound B–negative controls, age and gender matched 2:1. Principal component analysis of regional [18F]AV‐1451 tau‐PET standard uptake value ratio was performed to understand underlying patterns of [18F]AV‐1451 uptake independent of clinical diagnosis. Penalized multinomial regression analyses were utilized to assess diagnostic utility.ResultsLogopenic‐PPA showed striking uptake throughout neocortex, particularly temporoparietal, compared to controls, semantic‐PPA, and agrammatic‐PPA. Semantic‐PPA and agrammatic‐PPA showed milder patterns of focal [18F]AV‐1451 uptake. Semantic‐PPA showed elevated uptake (left>right) in anteromedial temporal lobes, compared to controls and agrammatic‐PPA. Agrammatic‐PPA showed elevated uptake (left>right) throughout prefrontal white matter and in subcortical gray matter structures, compared to controls and semantic‐PPA. The principal component analysis of regional [18F]AV‐1451 indicated two primary dimensions, a severity dimension that distinguished logopenic‐PPA from agrammatic‐PPA and semantic‐PPA, and a frontal versus temporal contrast that distinguishes agrammatic‐PPA and semantic‐PPA cases. Diagnostic utility of [18F]AV‐1451was superior to MRI and at least equal to FDG‐PET.Interpretation[18F]AV‐1451binding characteristics differ across the PPA variants and were excellent at distinguishing between the variants. [18F]AV‐1451binding characteristics were as good or better than other brain imaging modalities utilized in clinical practice, suggesting that [18F]AV‐1451 may have clinical diagnostic utility in PPA. Ann Neurol 2018 Ann Neurol 2018;83:599–611
Abstract GS3-08: Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRIAL
DeMichele, A., Symmans, F., Albain, KS, Hylton, NM, Forero‐Torres, Andres , Veer, LJ van't, Perlmutter, Jane , Rugo, HS, Melisko, Michelle , Krings, Gregor , Datnow, Brian, Hasteh, Farnaz, Tipps, Ann , Weidner, Noel, Tickman, Ronald, Thornton, Steven , Amin, K M, Chen, B, Keeney, Gary L., Ocal, Tolgay I., Klipfel, Nancy, Sattar, Husain, Mueller, Jeffery, Gwin, K, Zeck, Jay , Duan, Xiuzhen, Erşahin, Çağatay, Gamez, R, Troxell, Megan L. , Mansoor, Adnan , LeBeau, Lauren, Sams, Sharon B. , Wisell, J. , Wei, Shi , Vinh, Tuyethoa N., Stamatakos, MD, Tawfik, Ossama , Rendi, Mara H. , Minton, S., Magliocco, Anthony M., Sahoo, Sunati , Fang, Y, Singhrao, Ruby , Asare, SM, Wallace, AM, Chien, AJ, Ellis, ED, Han, HS, Clark, AS, Boughey, JC , Elias, AD, Nanda, Rita , Korde, Larissa A. , Northfelt, Donald W. , Edmiston, KK, Viscusi, Rebecca K., Haley, Barbara , Kemmer, Kathleen, Zelnak, Amelia, Berry, DA, Esserman, L., Yee, Douglas , Isaacs, Claudine , Yau, Christina , Chen, Yung‐Yi , Balassanian, Ronald , Zhang, Hongtao , Thornton, S, Ritter, Jacob , Klein, Martin , Feldman, Michael D. , Baker, Gabrielle M. , Kallakury, Bhaskar , Harada, Shuko , Fan, F, Adams, Amy Louise , Fang, Y, Hirst, Gillian L. , Murthy, Ravi , Lang, Julie E. , Khan, Qamar J.

Mayo Clinic

Cancer Research | February 15, 2018 | Volume: 78 | Issue: 4_Supplement | Pages: GS3-08-GS3-08

10.1158/1538-7445.sabcs17-gs3-08 Get It

Abstract Background: Pathological complete response (pCR) is accepted by FDA as a surrogate endpoint for accelerated approval of targeted agents in combination with chemotherapy based on better long-term outcomes compared to residual disease (Cortazar 2014). Methods: The multi-center, adaptively-randomized I-SPY2 platform trial uses pCR as the primary endpoint to identify investigational agents that will improve outcomes in women with stage 2/3 breast cancer with high risk of early recurrence, across all signatures, based on hormone receptor (HR), HER2, and 70-gene (MammaPrint) status. For patients with HR+ HER2- tumors, only 70-gene (Mammaprint) high-risk patients are enrolled. To date, 1200+ patients have been randomized to one of 14 arms: control (paclitaxel followed by AC); veliparib/carboplatin; neratinib; MK2206; trebananib; trastuzumab/pertuzumab; ado-trastuzumab emtansine/pertuzumab; pembrolizumabx4; ganitumab/metformin; ganetespib; PLX-3397. 7 agents graduated in at least one signature (> 85% probability of success in a 300-patient phase III confirmatory trial); 2 did not graduate; 1 stopped for toxicity, and 3 are enrolling (patritumab/trastuzumab, talazoparib/irinotecan, pembrolizumabx8). Local pathologists were centrally trained using the Residual Cancer Burden (RCB) assessment to ensure uniform evaluation and response classification; RCB 0 = pCR. Results: We evaluated the relationship between pCR and event free (EFS) and distant disease free survival (DDFS) in the first 522 pts (median follow-up:2.5 years). 180 pts achieved pCR (36%) while 338 did not (RCB=1-3). There were 82 EFS and 65 DRFS events. Over the entire group (including all arms), pCR was highly associated with 3-year EFS (p<0.001 for both). Pts achieving pCR had a 3% recurrence risk (RR) at 3 years; those with non-pCR had 24% RR over this time period. For distant recurrence, the 3-year RR with pCR was 2%, compared to 20% in pts with non-pCR. As expected, pCR rates varied by breast cancer subtype (HR+/HER2: 18% (35/196), HR+/HER2+: 40% (33/82), HR-/HER2+:68% (34/50), HR-/HER2-:41% (76/188)). The relationship between pCR and EFS was significant and clinically impactful within each subtype. 3-year survival (pCR group)Hazard Ratio OverallOverallHR+/HER2-HER2+TNBCEFS97%0.08 (0.03-0.23)0.14 (0.02-1.04)0 (NA)0.11 (0.03-0.37)DDFS98%0.08 (0.03-0.26)0.17 (0.01-1.23)0 (NA)0.09 (0.02-0.40) Conclusions: The first long-term efficacy results from the I-SPY2 TRIAL demonstrate that achieving pCR is a very strong surrogate endpoint for improved EFS and DDFS in a high-risk population, across all treatment arms, regardless of subtype. I-SPY2 shows substantially lower estimated EFS hazards for patients achieving pCR, compared to the 5 yr EFS hazard ratio for pCR vs not in Cortazar (hazard ratio 0.49), demonstrating important differences between a metaanalysis compared to a platform trial with uniform high-risk eligibility, standardized pathology assessment, and multiple targeted therapies. Our data support the use of pCR as a primary endpoint for accelerated approval of new drugs if EFS is evaluated in the same population. Based on these findings, the I-SPY2 TRIAL will test whether therapy can be deescalated or escalated for individual patients with the goal of achieving pCR for all. Citation Format: Yee D, DeMichele A, Isaacs C, Symmans F, Yau C, Albain KS, Hylton NM, Forero-Torres A, van't Veer LJ, Perlmutter J, Rugo HS, Melisko M, Chen Y-Y, Balassanian R, Krings G, Datnow B, Hasteh F, Tipps A, Weidner N, Zhang H, Tickman R, Thornton S, Ritter J, Amin K, Klein M, Chen B, Keeney G, Ocal T, Feldman M, Klipfel N, Sattar H, Mueller J, Gwin K, Baker G, Kallakury B, Zeck J, Duan X, Ersahin C, Gamez R, Troxell M, Mansoor A, Grasso LeBeau L, Sams S, Wisell J, Wei S, Harada S, Vinh T, Stamatakos MD, Tawfik O, Fan F, Adams A, Rendi M, Minton S, Magliocco A, Sahoo S, Fang Y, Hirst G, Singhrao R, Asare SM, Wallace AM, Chien AJ, Ellis ED, Han HS, Clark AS, Boughey JC, Elias AD, Nanda R, Korde L, Murthy R, Lang J, Northfelt D, Khan Q, Edmiston KK, Viscusi R, Haley B, Kemmer K, Zelnak A, Berry DA, Esserman LJ. Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRIAL [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr GS3-08.
Examination of Utricular Response Using oVEMP and Unilateral Centrifugation Rotation Testing
Zalewski, Christopher , Ackley, R. Steven, McCaslin, Devin L. , Clark, M. Diane , Hanks, Wendy D., Brewer, Carmen C.

Mayo Clinic

Ear & Hearing | February 11, 2018 | Volume: 39 | Issue: 5 | Pages: 910-921

10.1097/aud.0000000000000552 | PMID 29432406 Get It

Objectives: Significant advancements have been made toward the clinical assessment of utricular function through ocular vestibular-evoked myogenic potentials (oVEMP) and unilateral centrifugation (UCF) testing. To date, no study has examined intrasubject relationships between these measures. The study hypothesis was that intrasubject responses from oVEMP and UCF testing would be correlated inasmuch as both tests have been reported to assess utricular function. Design: UCF rotations and oVEMP testing were performed on healthy volunteers, aged 18 to 62 years. A within-subject study design compared and correlated UCF outcome measures of ocular counterroll, subjective visual vertical, and ocular counterroll–gravitational inertial acceleration slope against peak to peak oVEMP N1–P1 amplitude. Results: Correlational analyses failed to reveal any significant relationships between oVEMP amplitude and UCF responses suggesting that these tests may be inciting different response properties within the utricular system. Conclusions: Various anatomical and physiological differences within the utricle, in addition to the fundamental differences in stimulus properties between the oVEMP and UCF tests, could explain the lack of significant correlations between these measures and suggest that oVEMP and UCF testing may be complimentary in their evaluation of the utricular system. These data reinforce the complexities of the utricular system and provide further insight into the difficulties encountered in its clinical assessment.